Novyra Pharmachem share price
BSE: 519353Agricultural Food & other ProductsSmall Cap
NOVYRA PHARMACHEM LIMITED · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Apr 1994
Last close ₹8.08down ₹0.42 (4.94%)
Share price at the BSE close on 28 Oct 2026. Previous close ₹8.50.
28 Oct: open ₹8.08, high ₹8.08, low ₹8.08
52-week range of traded prices to 28 Oct 2026
₹7.12Low, 28 Oct 2025₹16.55High, 23 Mar 2026
- Under BSE's graded surveillance, stage 0, on the list for 27 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Next results date: the board meets on 2 Nov 2026 to consider: quarterly results. Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹5.11 Cr4,706th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 8.64
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −166.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −906.7%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 200
Results
Standalone; ₹ crore.Novyra Pharmachem quarterly results
Quarter to Jun 2026, against the quarter before
- RevenueRevenue. The pill is the change in revenue against the quarter before: this period's figure divided by that one's, less one, in per cent.
- ₹1.73 Crup 1,553.35%
- Net profitNet profit. Under it, net profit in the quarter before. A change in per cent is not worked out where either period is a loss or nothing. Net profit in the glossary
- −₹0.02 CrQuarter to Mar 2026: −₹5.34 Cr
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. Net margin in the glossary
- −1.2%
Revenue by quarter
Peak revenue ₹1.73 Cr, quarter to Jun 2026; lowest ₹0.00 Cr, quarter to Sep 2024
Net profit by quarter, a loss in red
- Net profit
- Loss
A loss in 7 of the 8 quarters shown
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 | 0.00 | 0.10 | 1.73 |
| Net profit | 0.00 | −0.01 | −0.05 | −0.01 | 0.00 | −0.01 | −5.34 | −0.02 |
| Net margin | – | – | – | – | 2.7% | – | −5,113.3% | −1.2% |
Standalone. The last eight quarters. The latest is shaded.
Year to Mar 2026, against the year before
- RevenueRevenue. Under it, revenue in the year before. A change in per cent is not worked out where either period is a loss or nothing.
- ₹0.10 CrYear to Mar 2025: ₹0.00 Cr
- Net profitNet profit. Under it, net profit in the year before. A change in per cent is not worked out where either period is a loss or nothing.
- −₹5.37 CrYear to Mar 2025: −₹0.06 Cr
- Net margin
- −5,147.3%
Revenue by year
Peak revenue ₹15 Cr, year to Mar 2021; lowest ₹0.00 Cr, year to Mar 2024
Net profit by year, a loss in red
- Net profit
- Loss
A loss in 6 of the 9 years with results on record
| ₹ crore | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.7 | 1.7 | 0.2 | 15.0 | 0.2 | 0.2 | 0.0 | 0.0 | 0.1 |
| Net profit | 0.0 | −0.1 | 0.0 | 5.9 | 0.0 | 0.0 | −0.2 | −0.1 | −5.4 |
| Net margin | −2.2% | −7.5% | −11.9% | 39.5% | 2.3% | 7.7% | – | – | −5,147.3% |
Standalone. Years to March. The latest is shaded. No results on record for the year to Mar 2017.
Business segments
Share of revenue, year to Mar 2026, standalone.Segment revenue and profit
- Tea EstateTea Estate, share of revenue. The segment's revenue as a percentage of the revenue of all the company's reported business segments together, leaving out eliminations between them and unallocated items.₹0.12 Cr73.1%
- Real EstateReal Estate, share of revenue. The segment's revenue as a percentage of the revenue of all the company's reported business segments together, leaving out eliminations between them and unallocated items.₹0.04 Cr20.9%
- PharmaPharma, share of revenue. The segment's revenue as a percentage of the revenue of all the company's reported business segments together, leaving out eliminations between them and unallocated items.₹0.01 Cr6.0%
Novyra Pharmachem competitors and peers
Tea & Coffee, 28 listed companies, priced on 28 Oct 2026. The table lists the 8 companies closest to Novyra Pharmachem in market cap. 2 companies in the table last traded before then: their rows are priced on their last trade.FMCG companies
| Company | ||||||||
|---|---|---|---|---|---|---|---|---|
 Shri Vasuprada PlantationsVASUPRADA | 78 | – | 0.65 | +11.3% | −142.5% | −3.2% | 0.4% | 0.00% |
 Warren TeaWARRENTEA | 50 | – | 0.52 | – | −288.2% | −2.5% | −3.7% | 0.00% |
 Diana Tea Co.Ltd.DIANATEA | 40 | 7.13 | 0.61 | +23.8% | – | 8.6% | 5.0% | 0.00% |
 Kanco Tea & IndustriesKANCOTEA | 32 | – | 0.57 | +20.8% | – | −8.8% | −4.0% | 0.00% |
 Tyroon Tea Co.TYROON | 29 | – | 0.72 | +0.1% | −223.0% | −3.2% | −7.5% | 0.00% |
 Octavius PlantationsOCTAVIUSPL | 11 | – | – | – | – | – | – | 0.00% |
 Indong Tea CompanyINDONG | 11 | – | 0.18 | −24.2% | −356.1% | −1.4% | −0.8% | 0.00% |
 Retro Green RevolutionRGRL | 5 | – | 0.12 | – | – | – | – | 0.00% |
Market cap in ₹ crore. Growth is the last twelve months against the twelve before. A figure is left empty where it would rest on a loss or the company has under a year of results on record. ROE is the shareholders' profit over their net worth. ROCE is profit before interest and tax over the whole group's net worth plus borrowings, as in the figures at the top of the page.
Latest announcements
Routine notices left out.Novyra Pharmachem announcements
Oct 2026
23 Oct · Board meeting
Meeting on 2 Nov 2026: quarterly results
Sep 2026
24 Sep
Aug 2026
22 Aug
14 Aug · Results
14 Aug · Results
Novyra Pharmachem share price by year
Each calendar year to 2025.Novyra Pharmachem share price history
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2025 | 15.55 | +177.2% | 15.55 | 5.60 |
| 2024 | 5.61 | +49.6% | 8.90 | 3.34 |
| 2023 | 3.75 | −54.0% | 9.82 | 3.75 |
| 2022 | 8.16 | +133.1% | 8.82 | 3.33 |
| 2021 | 3.50 | −32.7% | 5.20 | 3.07 |
| 2020 | 5.20 | −36.6% | 7.80 | 5.20 |
| 2019 | 8.20 | −9.4% | 8.60 | 8.20 |
| 2017 | 9.05 | – | 13.77 | 8.65 |
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before. 2025 is from its first session, 27 Feb 2025. 2024 is from its first session, 30 Jan 2024. 2020 is from its first session, 24 Jan 2020. 2019 is from its first session, 22 Jan 2019. 2017 is from its first session, 20 Jun 2017. The change in 2019 is on the close at the end of 2017, the last year before it with a trade. The close is the year's last trade for 2024 (22 Nov 2024), 2022 (16 Dec 2022), 2019 (21 Nov 2019) and 2017 (13 Nov 2017).
Recent sessions
The 9 trading days to 13 Oct 2026, as traded on BSE; the latest is at the top of the page.
| Date | Open | High | Low | Close | Average price | Volume |
|---|---|---|---|---|---|---|
| 13 Oct 2026 | 8.50 | 8.50 | 8.50 | 8.50 | 8.50 | 100 |
| 29 Sep 2026 | 8.71 | 8.71 | 8.71 | 8.71 | 8.71 | 100 |
| 22 Sep 2026 | 9.16 | 9.16 | 9.16 | 9.16 | 9.16 | 300 |
| 18 Sep 2026 | 10.14 | 10.14 | 9.64 | 9.64 | 9.66 | 2,000 |
| 10 Sep 2026 | 10.14 | 10.14 | 10.14 | 10.14 | 10.14 | 800 |
| 31 Aug 2026 | 10.67 | 10.67 | 10.67 | 10.67 | 10.67 | 100 |
| 21 Aug 2026 | 10.67 | 10.67 | 10.67 | 10.67 | 10.67 | 100 |
| 14 Aug 2026 | 10.67 | 10.67 | 10.67 | 10.67 | 10.67 | 200 |
| 13 Aug 2026 | 10.17 | 10.17 | 10.17 | 10.17 | 10.17 | 100 |
Prices in ₹ per share as traded, not adjusted.
Company details
- BSE code
- 519353
- ISIN
- INE856E01019
- Industry
- Agricultural Food & other Products
- Website
- www.novyrapharmachemltd.com
- CIN
- L15520GJ1987PLC171085
- Corporate identity number, the registrar of companies' code for it
- Incorporated
- 1987
- Registered office
- R S No 432, T P Scheme No 3, F P No 89/A, City Survey No 3763, Plot No C, Palky Plot No A, Ground Floor, Back Side, Pavthawala Compound B/h Zenith Mill, Vastadevadi Road, Surat 395004, Gujarat
- Share registrar
- S. K. Infosolutions Pvt. Ltd
- Keeps the register of shareholders and handles transfers and dividend payments